Literature DB >> 12401118

Natriuretic effect of caffeine: assessment of segmental sodium reabsorption in humans.

D G Shirley1, S J Walter, F H Noormohamed.   

Abstract

In order to assess the intrarenal mechanisms responsible for the natriuretic action of caffeine, the renal clearances of (51)Cr-EDTA [used as a measure of glomerular filtration rate (GFR)] and lithium (used as an index of end-proximal fluid delivery) were measured in eight healthy males before (control period) and immediately after (experimental period) a 400 mg oral dose of caffeine (given over 90 min) or placebo. In caffeine-treated subjects, the fractional excretion of sodium rose from 1.00+/-0.25% in the control period to 1.47+/-0.18% in the experimental period, while corresponding values on the placebo day were 1.04+/-0.16% and 0.70+/-0.07% respectively. GFR was unchanged following either caffeine or placebo. When compared with the placebo day, caffeine caused increases in lithium clearance (experimental period values: caffeine, 37+/-1 ml/min; placebo, 28+/-2 ml/min; P <0.001), the fractional excretion of lithium (caffeine, 34+/-1%; placebo, 26+/-2%; P <0.001) and the sodium/lithium clearance ratio (used as an index of the fraction of sodium delivered to the distal nephron that escapes reabsorption therein: caffeine, 4.4+/-0.3%; placebo, 2.8+/-0.2%; P <0.001). These results suggest that reduced fractional sodium reabsorption in both the proximal tubule and the distal nephron contributes to the acute natriuretic effect of caffeine. The data also confirm the importance of controlling caffeine intake when investigating renal function using lithium clearance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401118     DOI: 10.1042/cs1030461

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

Review 1.  Caffeine and diuresis during rest and exercise: A meta-analysis.

Authors:  Yang Zhang; Aitor Coca; Douglas J Casa; Jose Antonio; James M Green; Phillip A Bishop
Journal:  J Sci Med Sport       Date:  2014-08-09       Impact factor: 4.319

2.  Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients.

Authors:  Elaine M Worcester; Fredric L Coe; Andrew P Evan; Kristin J Bergsland; Joan H Parks; Lynn R Willis; Daniel L Clark; Daniel L Gillen
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-20

Review 3.  Adenosine, type 1 receptors: role in proximal tubule Na+ reabsorption.

Authors:  W J Welch
Journal:  Acta Physiol (Oxf)       Date:  2014-11-11       Impact factor: 6.311

Review 4.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

5.  Caffeine intake and the risk of kidney stones.

Authors:  Pietro Manuel Ferraro; Eric N Taylor; Giovanni Gambaro; Gary C Curhan
Journal:  Am J Clin Nutr       Date:  2014-10-01       Impact factor: 7.045

6.  Evidence for altered renal tubule function in idiopathic calcium stone formers.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Urol Res       Date:  2010-07-15

7.  Soda and other beverages and the risk of kidney stones.

Authors:  Pietro Manuel Ferraro; Eric N Taylor; Giovanni Gambaro; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-15       Impact factor: 8.237

8.  Premature baby with extreme hyponatraemia (95 mmol per litre): a case report.

Authors:  Arthur Abelian; Cristian Eugen Ghinescu
Journal:  BMC Pediatr       Date:  2015-09-16       Impact factor: 2.125

9.  Effect of coffee consumption on fetal renal artery blood flow and amniotic fluid volume in third trimester of pregnancy.

Authors:  Ilknur Col Madendag; Mefkure Eraslan Sahin; Emine Aydin; Yusuf Madendag
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

10.  Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.

Authors:  Katelyn A McKenzie; Mirelle El Ters; Vicente E Torres; Peter C Harris; Arlene B Chapman; Michal Mrug; Frederic F Rahbari-Oskoui; Kyongtae Ty Bae; Douglas P Landsittel; William M Bennett; Alan S L Yu; Jonathan D Mahnken
Journal:  BMC Nephrol       Date:  2018-12-27       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.